CDMO Injectable Drugs Market, By Product Type (Small Molecule Injectables and Large Molecule Injectables), By Drug Class (Antidiabetics, Cardiovascular Drugs, Anti-infectives, Analgesics and Anesthetics, Oncology Drugs, Vaccines, CNS Drugs, Hormonal Drugs, and Others), By Application (Oncology, Diabetes, Autoimmune Diseases, Hematological Disorders, Cardiovascular Diseases, Infectious Diseases, Neurological Disorders, Pain Management, Rare Diseases, and Others), By Route of Administration (Intramuscular (IM), Intravenous (IV), Subcutaneous (SC), and Others), By Scale of Operations (Preclinical Development, Clinical Development (Phases I–III), and Commercial / Large-Scale Manufacturing), By End User (Biopharmaceutical Companies, Generic Drug Manufacturers, Contract Research Organizations (CROs), and Academic and Research Institutes), By Geography (North America, Europe, Asia Pacific, Latin America, Middle East, and Africa) - Growth Trends and Forecasts (2026-2033)